Poland· PL-100496841
Emblaveo
A monobactams product containing aztreonamum + avibactamum, registered in Poland by Pfizer Europe MA EEIG.
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Aztreonamum + Avibactamum
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Poland (PL)
- ATC code
- J01DF
- ATC class
- Monobactams
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 1
- gtin05415062130803
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Aztreonamum + avibactamum in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaEMBLAVEOPfizer Europe MA EEIG, Bruxelles
- United StatesEMBLAVEOAbbVie Inc.
- SpainEMBLAVEO 1,5 G/0,5 G POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONPfizer Europe Ma Eeig
- FinlandEmblaveoPfizer Europe MA EEIG
- FranceEMBLAVEO 1,5 g/0,5 g, poudre pour solution à diluer pour perfusionPFIZER EUROPE MA EEIG (BELGIQUE)
- United KingdomEmblaveo 1.5g/0.5g powder for concentrate for solution for infusion vialsPfizer Ltd
- NetherlandsEmblaveo 1,5 g/0,5 g poeder voor concentraat voor oplossing voor infusiePfizer Europe MA EEIG
- NorwayEmblaveoPfizer Europe MA EEIG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Emblaveo
- Liechtenstein · Emblaveo
- Norway · Emblaveo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/138dcd5c-fc85-46e0-9a19-6964553a9935 GET /v1/drugs/138dcd5c-fc85-46e0-9a19-6964553a9935?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania koncentratu roztworu do infuzji",
"source": "urpl",
"strength": "1,5 g + 0,5 g",
"packaging": "05415062130803 ¦ Rpz ¦ EU/1/24/1808/001 ¦ 154303\n10 fiol. 30 ml",
"substance": "Aztreonamum 1.5 g + Avibactamum 0.5 g",
"common_name": "Aztreonamum + Avibactamum",
"pl_product_id": "100496841",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about aztreonamum + avibactamum.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.